The global kidney/renal function test market size reached USD 932.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,729.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.6% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 932.7 Million |
Market Forecast in 2033 | USD 1,729.2 Million |
Market Growth Rate (2025-2033) | 6.6% |
A kidney/renal function test is performed to diagnose and analyze defects in the overall functioning of the kidney. It relies on blood or urine samples to ensure that the kidney is filtering waste products. Some of the common symptoms of kidney-related problems include blood in urine, swelling in hands or feet and difficulty in urination due to a significant increase in body fluids. Nowadays, a kidney/renal function test can also be suggested by doctors if a patient is suffering from conditions that can impact the kidneys.
The rising prevalence of chronic kidney diseases (CKD) and acute kidney injury (AKI) represents one of the key factors driving the kidney/renal function test market growth. This can be accredited to changing lifestyles, increasing consumption of alcohol and the growing number of individuals suffering from hypertension and diabetes. Apart from this, key players are investing in research and development (R&D) activities for introducing advanced testing products that provide early and efficient disease diagnosis. In addition, increasing healthcare expenditure and the presence of well-established healthcare infrastructure are also contributing to the market growth. Furthermore, public and private health organizations are undertaking numerous initiatives to spread awareness about kidney-related diseases and available disease testing facilities. For instance, in the United States, the National Kidney Foundation (NKF) collaborated with the National Committee for Quality Assurance (NCQA) to introduce a new kidney health evaluation measure, especially for patients with diabetes.
IMARC Group provides an analysis of the key trends in each sub-segment of the global kidney/renal function test market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on test type, product and end use.
Breakup by Test Type:
Breakup by Product:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 77 Elektronika Kft., Abbott Laboratories, Acon Laboratories, Inc., Arkray, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Nova Biomedical, Quest Diagnostics Incorporated, Randox Laboratories Ltd., Siemens Healthcare GmbH, and Sysmex Corporation.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Test Type, Product, End Use, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 77 Elektronika Kft., Abbott Laboratories, Acon Laboratories, Inc., Arkray, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Nova Biomedical, Quest Diagnostics Incorporated, Randox Laboratories Ltd., Siemens Healthcare GmbH, Sysmex Corporation |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report: